Literature DB >> 22747190

The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials.

Matthew P Pase1, James Kean, Jerome Sarris, Chris Neale, Andrew B Scholey, Con Stough.   

Abstract

OBJECTIVES: Traditional knowledge suggests that Bacopa monnieri enhances cognitive performance. Such traditional beliefs have now been scientifically tested through a handful of randomized, controlled human clinical trials. The current systematic review aimed to examine the scientific evidence as to whether Bacopa can enhance cognitive performance in humans.
DESIGN: A systematic review of randomized controlled trials is presented. Multiple databases were systematically searched by multiple authors. Relevant trials were objectively assessed for methodological quality.
SUBJECTS: The subjects studied were adult humans without dementia or significant cognitive impairment.
INTERVENTIONS: B. monnieri, including Bacopa extracts, were administered over long-term supplementation periods. OUTCOME MEASURES: Any validated cognitive test, whether a primary or secondary outcome.
RESULTS: Six (6) studies met the final inclusion criteria and were included in review. Trials were all conducted over 12 weeks. Across trials, three different Bacopa extracts were used at dosages of 300-450 mg extract per day. All reviewed trials examined the effects of Bacopa on memory, while other cognitive domains were less well studied. There were no cognitive tests in the areas of auditory perceptual abilities or idea production and only a paucity of research in the domains of reasoning, number facility, and language behavior. Across studies, Bacopa improved performance on 9 of 17 tests in the domain of memory free recall. There was little evidence of enhancement in any other cognitive domains.
CONCLUSIONS: There is some evidence to suggest that Bacopa improves memory free recall with evidence for enhancement in other cognitive abilities currently lacking perhaps due to inconsistent measures employed by studies across these cognitive domains. Research into the nootropic effects of Bacopa is in its infancy, with research still yet to investigate the effects of Bacopa across all human cognitive abilities. Similarly, future research should examine the nootropic effects of Bacopa at varied dosages and across different extracts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22747190     DOI: 10.1089/acm.2011.0367

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  28 in total

Review 1.  Herbal medicine in the treatment of Alzheimer's disease.

Authors:  Jian-guo Wu; Yan-yan Wang; Zi-lv Zhang; Bin Yu
Journal:  Chin J Integr Med       Date:  2014-04-22       Impact factor: 1.978

Review 2.  Cognitive effects of two nutraceuticals Ginseng and Bacopa benchmarked against modafinil: a review and comparison of effect sizes.

Authors:  Chris Neale; David Camfield; Jonathon Reay; Con Stough; Andrew Scholey
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

Review 3.  Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

4.  The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain.

Authors:  Michelle D Nemetchek; Andrea A Stierle; Donald B Stierle; Diana I Lurie
Journal:  J Ethnopharmacol       Date:  2016-07-26       Impact factor: 4.360

Review 5.  Neurocognitive Effect of Nootropic Drug Brahmi (Bacopa monnieri) in Alzheimer's Disease.

Authors:  Kaustubh S Chaudhari; Nishant R Tiwari; Rakesh R Tiwari; Rohan S Sharma
Journal:  Ann Neurosci       Date:  2017-05-12

6.  Optimization of calcium gluconate and Bacopa monniera extract levels in calcium enriched herbal ice cream by response surface methodology.

Authors:  M Davuddin Baig; A Malik; M Dharani Kumar; M Bumbadiya; S N Rajakumar; A K Beena
Journal:  J Food Sci Technol       Date:  2019-06-10       Impact factor: 2.701

7.  Seasonal variations in harvest index and bacoside A contents amongst accessions of Bacopa monnieri (L.) Wettst. collected from wild populations.

Authors:  Mahima Bansal; M Sudhakara Reddy; Anil Kumar
Journal:  Physiol Mol Biol Plants       Date:  2016-07-26

8.  Brahmi for the better? New findings challenging cognition and anti-anxiety effects of Brahmi (Bacopa monniera) in healthy adults.

Authors:  Vidya Sathyanarayanan; Tinku Thomas; Suzanne J L Einöther; Rajendra Dobriyal; M K Joshi; Srinivasan Krishnamachari
Journal:  Psychopharmacology (Berl)       Date:  2013-01-26       Impact factor: 4.530

Review 9.  Neuropharmacological review of the nootropic herb Bacopa monnieri.

Authors:  Sebastian Aguiar; Thomas Borowski
Journal:  Rejuvenation Res       Date:  2013-08       Impact factor: 4.663

10.  A randomized controlled trial investigating the effect of Pycnogenol and Bacopa CDRI08 herbal medicines on cognitive, cardiovascular, and biochemical functioning in cognitively healthy elderly people: the Australian Research Council Longevity Intervention (ARCLI) study protocol (ANZCTR12611000487910).

Authors:  Con K Stough; Matthew P Pase; Vanessa Cropley; Stephen Myers; Karen Nolidin; Rebecca King; David Camfield; Keith Wesnes; Andrew Pipingas; Kevin Croft; Dennis Chang; Andrew B Scholey
Journal:  Nutr J       Date:  2012-03-06       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.